(Q37849626)

24 August 2017

1 reference

title

The effect of etomidate on adrenal function in critical illness: a systematic review (English)

1 reference

24 August 2017

1 reference

1 reference

Stewart G Albert

1

1 reference

PubMed ID

21373823

24 August 2017

Srividya Ariyan

series ordinal

2

1 reference

PubMed ID

21373823

24 August 2017

Ayesha Rather

series ordinal

3

1 reference

24 August 2017

4 March 2011

1 reference

24 August 2017

Intensive Care Medicine

1 reference

24 August 2017

37

1 reference

24 August 2017

901-910

1 reference

24 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-011-2160-1

24 August 2017

0 references

cites work

A review of etomidate for rapid sequence intubation in the emergency department

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

ICU physicians should abandon the use of etomidate!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Influence of sedation on mortality in critically ill multiple trauma patients

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/21373823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Adrenocortical dysfunction following etomidate induction in emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Duration of adrenal inhibition following a single dose of etomidate in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Etomidate, sepsis, and adrenal function: not as bad as we thought?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Adrenal function in sepsis: the retrospective Corticus cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Increased Risk of Adrenal Insufficiency Following Etomidate Exposure in Critically Injured Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Predicting a low cortisol response to adrenocorticotrophic hormone in the critically ill: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Adrenal response in patients with septic shock of abdominal origin: relationship to survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Rapid sequence induction in the emergency department: induction drug and outcome of patients admitted to the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

A prospective observational study of the effect of etomidate on septic patient mortality and length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2160-1

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21373823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00134-011-2160-1

1 reference

24 August 2017

1 reference

PubMed ID

21373823